May 1, 2015
Researchers at UC San Diego School of Medicine conducted the first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and…
November 20, 2018
A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.
July 30, 2020
Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.
October 10, 2022
More than 100 UC San Diego Health physicians have been named “Top Docs” in the 2022 San Diego Magazine “Physicians of Exceptional Excellence” survey.
July 23, 2021
Senate President Pro Tempore Toni Atkins visited UC San Diego Medical Center today to recognize a $30 million allocation in the 2021-2022 California state budget that will support the redevelopment of the new Hillcrest hospital.
June 15, 2023
UC San Diego scientists discover shattered chromosomal fragments are tethered together during cell division before being rearranged; destroying the tether may help prevent cancerous mutations
December 5, 2023
The San Diego-based McGrath Family Foundation has pledged $25 million to support the new outpatient pavilion at UC San Diego Health – Hillcrest Medical Campus, slated to open in 2025. In recognition of the gift, the facility will be named the McGrath Family Foundation Outpatient Pavilion.
March 20, 2012
…research, specifically in radiation oncology. Standing beside a map with pins indicating all of the places previous UC San Diego medical students have gone, he says he’s hoping for a spot in California or the northeast. Anshu Abhat, 26, has been at UC San Diego for eight years, first as…
April 20, 2014
Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered a biomarker called CD61 on the surface of drug-resistant tumors that appears responsible for inducing tumor metastasis by enhancing…
January 23, 2012
UC San Diego Health System has received approval to acquire the Nevada Cancer Institute (NVCI), the official cancer institute of the state of Nevada, as an affiliate health care provider. The expansion represents a partnership between California and Nevada in offering lifesaving cancer care to patients through expert diagnosis, novel…
